Advertisements



Provention Bio expects results of inflammatory bowel disease trials in 2H19

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

Provention Bio sees results of inflammatory bowel disease trials in 2H19

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

Protagonist Therapeutics begins Phase 1 trial of inflammatory bowel disease drug

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 13th, 2018

UPMC Health Plan announces $6.3M research contract

UPMC Health Plan announced that the UPMC Center for High-Value Health Care was recently awarded a $6.3 million contract from the Patient-Centered Outcomes Research Institute (PCORI) to improve outcomes for patients with inflammatory bowel disease (.....»»

Category: topSource: bizjournalsSep 25th, 2018

Novan Rallies On Positive Early Results For Inflammatory Skin Disease Medication

Novan Inc (NASDAQ: NOVN) shares were advancing strongly Monday after the announcement of positive results for its pipeline candidate SB414. read more.....»»

Category: blogSource: benzingaAug 20th, 2018

Akari Announces First Quarter 2018 Financial Results and Update on its Growing Pipeline of Phase II and Phase III Clinical Trials

Opened three clinical trials in 2018 Trials in which complement dysregulation is the primary disease driver CAPSTONE, the Phase III trial in naïve paroxysmal nocturnal hemoglobinuria (PNH), in which patient treatment has commenced Phase II U.S. trial f.....»»

Category: earningsSource: benzingaAug 17th, 2018

Good Bacteria Could Be Used to Fight Gut Diseases, New Research Suggests

The findings could lead to a treatment for inflammatory bowel disease......»»

Category: topSource: newsweekJul 4th, 2018

RBC Capital Markets Expects Redfin"s Revenue Growth To Be Consistent Year-Over-Year

Redfin Corp (NASDAQ: RDFN) reported solid fourth-quarter results Thursday and mixed Q1 guidance. Latest Rat.....»»

Category: blogSource: benzingaFeb 15th, 2019

United States Cellular (USM) to Report Q4 Results: Wall Street Expects Earnings Growth

Zacks.....»»

Category: topSource: redinewsFeb 15th, 2019

JPMorgan Goes Crypto With New JPM Coin

JPMorgan Chase, the country's largest bank, announced Thursday morning that it will begin trials of a new cryptocurrency it expects to speed up money transfers and reduce risks for users......»»

Category: blogSource: 247wallstFeb 14th, 2019

The Street Debates What To Do With Yelp Stock After Q4 Beat

The crowdsourced review platform Yelp Inc (NYSE: YELP) reported Wednesday with fourth-quarter results that easily beat expectations and said it expects revenue to gr.....»»

Category: earningsSource: benzingaFeb 14th, 2019

Ubiquiti expects to achieve FY results within guidance range previously provided

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 8th, 2019

Jefferies expects in-line results, guidance from Carbonite

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 7th, 2019

Amicus announces results from Phase 1/2 Pompe disease study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 5th, 2019

Cigna Expects Minimal Impact From Drug-Rebate Proposal

Cigna said a federal proposal that would curb rebates from drugmakers would have minimal impact on its results and offered conservative earnings guidance for 2019, the first year it will include the operations of Express Scripts......»»

Category: smallbizSource: wsjFeb 2nd, 2019

Dell EMC eyes cloud transformation opportunities from Greater China

With strong results from its server operation in 2018, Dell EMC expects Greate.....»»

Category: topSource: digitimesJan 31st, 2019

KeyBanc expects continued cloud strength when Microsoft reports results

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 30th, 2019

The Daily Biotech Pulse: Roche Scraps Alzheimer"s Disease Trials, Amgen Issues Weak Guidance

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Jan. 29) read more.....»»

Category: blogSource: benzingaJan 30th, 2019

The Daily Biotech Pulse: Roche Scraps Alzheimer"s Disease Trials, Amgen Issues Weak Guidance

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The P.....»»

Category: earningsSource: benzingaJan 30th, 2019

Nucor"s (NUE) Earnings, Revenues Trounce Estimates in Q4

Higher steel prices and shipments drove Nucor's (NUE) Q4 results. The company expects strong earnings per.....»»

Category: smallbizSource: nytJan 29th, 2019

Earnings Watch: Harley-Davidson hits rough road, and now all eyes move to Apple

Harley-Davidson Inc. expects a slow start to the year, and didn’t do so well last year either. In the afternoon, all eyes will be on Apple’s results, though some of the suspense is gone......»»

Category: topSource: marketwatchJan 29th, 2019